Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States

Vaccine

Volumn 30, Issue 5, 2012, Pages 941-947

  Santibanez, Tammy A ^a   Shefer, Abigail ^a   Briere, Elizabeth C ^a   Cohn, Amanda C ^a   Groom, Amy V ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Haemophilus influenzae type b (Hib); Vaccination coverage; Vaccine shortages

Indexed keywords

DTAP HIB; DTAP IPV HIB; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPB HIB; UNCLASSIFIED DRUG;

ARTICLE; CHILD; DEMOGRAPHY; DRUG SHORTAGE; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B INFECTION; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NATIONAL IMMUNIZATION SURVEY; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; BACTERIAL CAPSULES; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; UNITED STATES; YOUNG ADULT;

EID: 84855457642     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.075     Document Type: Article

References (22)

1. ®). MMWR Morb Mortal Wkly Rep 2007, 56(December (50)):1318-1320.
2. CDC Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB® and Comvax®). MMWR 2007, 56(December):1-2. Dispatch.
3. Kempe A., Babbel C., Wallace G., et al. Knowledge of interim recommendations and use of Hib vaccine during vaccine shortages. Pediatrics 2010, 125:914-920.
4. CDC Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: reinstatement of the bosster dose at ages 12-15 months. MMWR Morb Mortal Wkly Rep 2009, 58:673-674.
5. CDC Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine. MMWR Morb Mortal Wkly Rep 2009, 58(September (36)):1008-1009.
6. CDC National, state, and local area vaccination coverage among children aged 19-35 months - United States, 2008. MMWR Morb Mortal Wkly Rep 2009, 58(August (33)):921-926.
7. CDC Invasive Haemophilus influenzae type b disease in five young children - Minnesota, 2008. MMWR 2009, 58(January(3)):58-60.
8. White K.E., Pabst L.J., Cullen K.A. Up-to-date haemophilus influenzae type b vaccination coverage during a vaccine shortage. Pediatrics 2011, 127:e707-e712.
9. CDC Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage - National Immunization Survey, United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(August(33)):1069-1072.
10. Smith P.J., Battaglia M.P., Huggins V.J., et al. Overview of the sampling design and statistical methods used in the National Immunization Survey. Am J Prev Med 2001, 20(4S):17-24.
11. Smith PJ, Rao JNK, Battaglia MP, Ezzati-Rice TM, Daniels D, Khare M. Compensating for provider nonresponse using response propensities to form adjustment cells: the National Immunization Survey. National Center for Health Statistics 20012(133):1-17. Available from: http://www.cdc.gov/nchs/data/series/sr_02/sr02_133.pdf.
12. Smith PJ, Hoaglin DC, Battaglia MP, Khare M, Barker LE. Statistical methodology of the National Immunization Survey, 1994-2002. National Center for Health Statistics 2005 March2(138)Available from: http://www.cdc.gov/nchs/data/series/sr_02/sr02_138.pdf.
13. Zell E.R., Ezzati-Rice T., Battaglia M.P. National Immunization Survey: the methodology of a vaccination surveillance system. Public Health Rep 2000, 115:65-77.
14. Frankel LR. The report of the CASRO Task Force on Response Rates. In: Wiseman F, editor. Improving data quality in sample surveys.Cambridge, MA, Marketing Science Institute, 1983.
15. Fairbrother G., Broder K., Staat M.A., et al. Pediatricians' adherence to pneumococcal conjugate vaccine shortage recommendations in 2 national shortages. Pediatrics 2007, 120:e401-e409.
16. Ward J.I., Lum M.K., Hall D.B., Silimperi D.R., Bender T.R. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis 1986, 153(1):17-26.
17. Wenger J.D., Ward J.I., Broome C.V. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis. Curr Clin Top Infect Dis 1989, 306-339.
18. Santibanez T.A., Santoli J.M., Barker L.E. Differential Effects of the DTaP and MMR Vaccine Shortages on Timeliness of Childhood Vaccination Coverage. Am J Public Health 2006 Feb 28, 96(4):691-696.
19. Freed G.L., Davis M.M., Clark S.J. Variation in public and private supply of pneumococcal conjugate vaccine during a shortage. JAMA 2003 Feb 5, 289(5):575-578.
20. National Vaccine Advisory Committee Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA 2003, 290(December(23)):3122-3128.
21. National Vaccine Advisory Committee. Strengthening the supply of routinely recommended vaccines in the United States. U.S. Department of Health and Human Services, National Vaccine Program Office; 2003 Jan.
22. United States General Accounting Office. Childhood vaccines: ensuring an adequate supply poses continuing challenges. Washington, DC; 2002 Sep. Report No.: GAO-02-987.